Unraveling the interplay between tau seeding and autophagy processes

Together, my in vitro and in vivo studies are starting to unravel the molecular details of the interplay between tau seeding and autophagy. These studies have the ability to reveal novel strategies to reduce the toxicity of tau aggregates by stimulating the activity of the autophagic machinery. Research approaches addressing tau in general, and tau seeding more specifically, have enormous potential to provide highly innovative, disease-modifying first-in-class therapeutics for AD. References 1) Holmes BB et al. (2014) "Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci USA. 111: E4376-E4385 2) Doench JG et al. (2016) "Optimized sgRNA design to maximise activity and minimise off-target effects of CRISPR-Cas9." Nat. Biotechnol. 34: 184-191.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.089660
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unraveling the interplay between tau seeding and autophagy processes

Michela Serresi, Susanne Wegmann, Matthias Jürgen Schmitt, Lisa Diez et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Unraveling the interplay between tau seeding and autophagy processes

Michela Serresi, Susanne Wegmann, Matthias Jürgen Schmitt, Lisa Diez, Lydia Brusendorf, Stephanie Beetz, Annett Böddrich, Annika Deckert, Gaetano Gargiulo
article en

Abstract

Together, my in vitro and in vivo studies are starting to unravel the molecular details of the interplay between tau seeding and autophagy. These studies have the ability to reveal novel strategies to reduce the toxicity of tau aggregates by stimulating the activity of the autophagic machinery. Research approaches addressing tau in general, and tau seeding more specifically, have enormous potential to provide highly innovative, disease-modifying first-in-class therapeutics for AD. References 1) Holmes BB et al. (2014) "Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci USA. 111: E4376-E4385 2) Doench JG et al. (2016) "Optimized sgRNA design to maximise activity and minimise off-target effects of CRISPR-Cas9." Nat. Biotechnol. 34: 184-191.

Alzheimer s & DementiaVol. 20(S1)
Max Delbrück Center (DE), German Center for Neurodegenerative Diseases (DE)
Openalex Percentile: Top 66%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unraveling the interplay between tau seeding and autophagy processes — Michela Serresi, Susanne Wegmann, et al. · Alzheimer s & Dementia (2024) | TGRS Research Map | TGRS